Gastroesophageal reflux disease (GERD) is a digestive disorder that affects the ring of muscle between the esophagus and stomach. It occurs when stomach acid flows back into the esophagus, a tube connecting the mouth and stomach. This acid reflux irritates the lining of the esophagus. Most people experience moderate to severe acid reflux from time to time. Some can manage the discomfort of Gastroesophageal reflux disease with over-the-counter medications and lifestyle changes. But some people require stronger medications or surgery to ease symptoms.
The “Global Gastroesophageal Reflux Disease Device Market” is anticipated to grow at a CAGR of around 2.97% during the forecast period, i.e., 2021-26, says MarkNtel Advisors. The main symptom of GERD is recurrent & troublesome heartburn & regurgitation. It affects approximately 20% of the adult population in the US. Around 17% of the European population, i.e., over 127 million people in Europe, suffer from GERD every week. It adversely affects the quality of life and can further cause esophageal cancer. The treatment options include lifestyle modifications, devices, or endoscopic procedures.
The global market is driven primarily by the increasing awareness regarding GERD and the rising prevalence of GERD-related disorders. Further, lifestyle changes and the mounting rate of obesity-driven GERD also boost the market, further states the research report, “Global Gastroesophageal Reflux Disease Device Market Analysis, 2021.”
|Study Period||Historical Data: 2016-19|
|Base Year: 2020|
|Forecast Period: 2021-26|
|Regions Covered||North America: USA, Canada|
|Europe: Germany, UK, France, Italy, Sweden, Switzerland|
|Asia-Pacific: China, India, Japan, Australia, Taiwan, ASEAN, New Zealand|
|South America: Brazil, Mexico|
|Middle East & Africa: UAE, Saudi Arabia, Turkey|
|Key Companies Profiled||Torax Medical, Inc., Pentax Medical, Medtronics Plc, MediGus Limited, Essai Co, Ltd., Medari Theraputics Inc., Takeda Pharmaceuticals Co. Ltd., Johnson & Johnson Services Inc., Olympus Corporation, Diversatek, Inc.|
|Unit Denominations||USD Million/Billion|
Impact of COVID-19 Outbreak on the Global Gastroesophageal Reflux Disease Device Market
2020 came as a catastrophic year for almost all industries due to the Covid-19 pandemic that severely targeted the Global Gastroesophageal Reflux Disease Device Market. As many hospital resources were allocated primarily to curb the pandemic and most government authorities & healthcare systems deferred optional or semi-optional procedures, the demand & sales of Gastroesophageal Reflux Disease Devices declined.
With people avoiding seeking treatment for non-COVID-19 procedures and hospitals critically focusing on purchasing ventilators & patient monitoring equipment required for treating COVID-19 patients, the leading market players witnessed severe massive losses. Hence, these aspects negatively impacted the global market growth amidst the crisis.
However, with the ease of norms & hassle-free access to non-essential treatments, the production & demand of GERD devices increased. It's safe to say that the global market is likely to return to its usual pace in the coming years.
By Product Type:
Growing Adoption of Esophagoscopes & Gastroscopes
Esophagoscope is an endoscope inserted through the mouth or the nares into the esophagus. It allows visualization of the esophageal mucosa from the upper esophageal sphincter to the gastric junction. On the other hand, Gastroscopes are forward-viewing endoscopes with insertion tubes designed to view the esophagus, stomach, & duodenum.
The surging prevalence of gastrointestinal bleeding, gastroesophageal reflux diseases, stomach cancer, etc., is projected to infuse the demand for endoscopy procedures. It, in turn, would propel the adoption of esophagoscopes & gastroscopes.
According to the American Cancer Society, in 2021, there will be around 26,560 new cases of gastric cancer and 180 deaths from it. Hence, the increase in gastric cancer cases is projected to boost the demand for esophagoscopes & gastroscopes and fuel the overall market growth in the years to come.
By Device Type:
Demand for MUSE (Medigus Ultrasonic Surgical Endostapler) to Witness Fastest Growth During 2021-26
The surging inclination toward MUSE over laparoscopic procedures is primarily because the latter process is time-taking & involves more invasive surgeries. Besides, MUSE ensures reduced hospital stays & post-procedure recovery times, which, in turn, helps in cost savings. Hence, the benefits cited above are the prime aspects augmenting the demand for MUSE in the coming years.
MUSE (Medigus Ultrasonic Surgical Endostapler) incorporates the latest technological advancements and combines micro visual, ultrasonic, and surgical stapling capabilities into one device. It allows the physician to perform the entire procedure efficiently in approximately one hour.
Further, it helps them deliver a patient-friendly treatment like Transoral Fundoplication (TF), i.e., to treat the root cause of GERD. Hence, it has immense potential to enhance the life quality of people suffering from GERD.
North America Dominated the Global Gastroesophageal Reflux Disease Device Market
Gastroesophageal Reflux Disease is one of the most commonly diagnosed digestive ailments in the US, with a prevalence of 20%. The rapidly expanding geriatric population & obesity rate in various North American countries leading to a surge in GERD cases are the prime factors that led North America to dominate the market.
Additionally, sedentary lifestyles, frequent smoking, & excessive alcohol consumption also contribute to the increasing occurrences of GERD, thereby propelling the demand for GERD devices. Moreover, the burgeoning number of patient visits in clinics is another crucial aspect escalating the demand for GERD devices in the region and fueling the overall market growth.
Sedentary Lifestyle Shift to Push the Global Gastroesophageal Reflux Disease Device Market
Lifestyle evolution and several environmental factors contribute to the rise in GERD cases. The lifestyle-related factors fueling the instance of GERD include obesity, sedentary habits, zero or little physical activities, and excessive consumption of coffee, tea, & peppermint. Further, an increase in stress levels, coupled with shorter dinner-to-bed time, also causes GERD, which, in turn, is driving the market.
Key Questions Answered in the Market Research Report:
Frequently Asked Questions
A. The Global Gastroesophageal Reflux Disease Device Market is projected to grow at a CAGR of around 2.97% during 2021-26.
A. The demand for MUSE (Medigus Ultrasonic Surgical Endostapler) is expected to attain the highest CAGR during the forecast period.
A. North America shall continue to grow at the highest CAGR during 2021-26 and present immense opportunities to the leading players in the Global Gastroesophageal Reflux Disease Device Market
A. Sedentary lifestyles and increasing geriatric population & obesity rate are the major factors causing GERD, thereby fueling the demand for GERD devices.
A. Post-COVID-19 Pandemic, the Global Gastroesophageal Reflux Disease Device Market is expected to grow steadily owing to an increase in the patient visits for GERD diagnosis & treatment.